7 / 23
Page 53
allied
academies
J Med Oncl Ther 2017 | Volume 2 Issue 4
Oncology and Biomarkers Summit
November 27-28, 2017 | Atlanta, USA
Annual Congress on
A
new systems approach to diseased states and wellness
result in a new branch in the healthcare services, namely,
personalized medicine (PM). To achieve the implementation
of PM concept, it is necessary to create a fundamentally
new strategy based upon the subclinical recognition of
biopredictors of hidden abnormalities long before the
disease clinically mani-fests itself. Each decision-maker
values the impact of their decision to use PM on their own
budget and well-being, which may not necessarily be optimal
for society. It would be ex-tremely useful to integrate data
harvesting from different databanks for applications such as
prediction and personalization of further treatment to thus
provide more tailored measures for the patients resulting
in improved patient outcomes, reduced adverse events and
more cost-effective use of health care resources. A lack of
medical guidelines has been identified by most responders as
the predominant barrier for adoption, indicating a need for
the develop-ment of best practices and guidelines to support
the implementation of PM. Implementation of PM requires
a lot before the current model “physician-patient” could
be gradually dis-placed by a new model “medical advisor-
healthy person-at-risk”. This is the reason for de-veloping
global scientific, clinical, social and educational projects in
PM to elicit the content of the new branch.
e:
ssuchkov57@gmail.comPersonalized and precision medicine as a model of healthcare of the newest generation to get armed with
innovative translational platforms, new knowledge and tools, upgraded education andmentality to secure
the impact of the latter
Sergey Suchkov
I M Sechenov First Moscow State Medical University, Russia